PATENT CLAIM ANALYSIS

Application Number: 15781303
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "210160"]

Abstract:
The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Claim (Index 12):
The method of  claim 1 , wherein the effective amount of the compound is in a range of from about 0.001 mg/kg/day to about 500 mg/kg/day.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 94.0
- Lexical Diversity: 2.23529
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14160180', '14242282', '13812366', '13653192', '14363051']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7746744418035683
- 35 USC 102 Novelty (BERT): 0.5346938691409372
- Combined Prediction Score: 0.7506763845373052
- Mean Citation Score: 296.341898
- Max Citation Score: 358.8583
- Similarity Product: 206.1478459646285

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test